Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 2, 2006, Pages 281-287

  Stenvinkel, Peter ^a   Rodríguez Ayala, Ernesto ^a   Massy, Ziad A ^a   Qureshi, Abdul Rashid ^a   Barany, Peter ^a   Fellström, Bengt ^a   Heimburger, Olof ^a   Lindholm, Bengt ^a   Alvestrand, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXIDASE;

ARTICLE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEROXIDASE; RENAL DIALYSIS;

EID: 34548419687     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01281005     Document Type: Article

References (0)